Hodgkins - update on treatment strategies in children and adolescents

First outcome results from MINDACT breast cancer clinical trial

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

Paediatric and adult high grade gliomas: A tale of a histone tail

Galectins in tumour immunity

Multiplex IHC as biomarkers for cancer immunotherapy

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer

Understanding personalised medicine - the e-learning course

Mechanisms of immune escape in non-Hodgkin lymphoma

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

Repopulation of cancer stem cells in therapeutic resistance